1. Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer
- Author
-
Mikiko Hashisako, Takeshi Kitazaki, Naohiro Matsuyama, Hideyuki Hayashi, Kazuto Ashizawa, Kazuhiro Tabata, Masataka Uetani, Kazuto Shigematsu, Mayumi Otsubo, Sumihisa Honda, Takeshi Nagayasu, Mio Mori, and Minoru Fukuda
- Subjects
Male ,0301 basic medicine ,enon-small cell lung cancer ,Lung Neoplasms ,Lymphadenopathy ,Computed tomography ,Anaplastic lymphoma kinase ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,hemic and lymphatic diseases ,Epidermal growth factor receptor ,Aged, 80 and over ,Gene Rearrangement ,medicine.diagnostic_test ,biology ,General Medicine ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,ErbB Receptors ,histological subtyp ,Oncology ,030220 oncology & carcinogenesis ,Original Article ,Female ,Non small cell ,histological subtype ,medicine.symptom ,Adult ,Pulmonary and Respiratory Medicine ,non‐small cell lung cancer ,lcsh:RC254-282 ,Lesion ,03 medical and health sciences ,medicine ,Humans ,Lung cancer ,Aged ,Retrospective Studies ,Emphysema ,ALK Gene Rearrangement ,business.industry ,computed tomography ,Original Articles ,medicine.disease ,respiratory tract diseases ,030104 developmental biology ,Egfr mutation ,Mutation ,Cancer research ,biology.protein ,Tomography, X-Ray Computed ,business ,epidermal growth factor receptor - Abstract
Background: The study was conducted to evaluate the clinical and computed tomography (CT) findings of non-small cell lung cancer (NSCLC) patients to distinguish between ALK gene rearrangement, EGFR mutation,and non-ALK/EGFR (no genetic abnormalities). Methods: We enrolled 201 patients with primary NSCLC who had undergone molecular testing for both ALK gene rearrangement and EGFR mutation. The clinical features and CT findings of the main lesion and associated pulmonary abnormalities were investigated.Results: Female gender (P = 0.0043 vs. non-ALK/EGFR), young age (P = 0.0156 vs. EGFR),and a light or never smoking history (P = 0.0039 vs. non-ALK/EGFR) were significant clinical characteristics of NSCLC with ALK gene rearrangement. The significant CT characteristics compared to NSCLC with EGFR mutation were a large mass (P = 0.0155), solid mass (P = 0.0048), and no air bronchogram (P = 0.0148). A central location (P = 0.0322) and lymphadenopathy (P =0.0353) were also more frequently observed. Coexisting emphysema was significantly less frequent in NSCLC patients with ALK gene rearrangement (P = 0.0135) than non-ALK/EGFR. Conclusions: NSCLC with ALK gene rearrangement was more likely to develop in younger women with a light or never smoking history. The characteristic CT findings of NSCLC with ALK gene rearrangement were a large solid mass, less air bronchogram, a central location, and lymphadenopathy., Thoracic Cancer, 10(4), pp.872-879; 2019
- Published
- 2019